Hypoglycemia has been considered to be one of the main barriers to good glycemic control, resulting in patients becoming unwilling to optimize treatment with insulin and in clinicians conservatively recommending more aggressive treatment targets [28]. This evidence concerns the gene INS and Hypoglycemia.